Xxii news fda 2018
Here are some notable news stories related to the FDA (Food and Drug Administration) in 2018:
January 2018
- FDA approves first generic version of EpiPen: The FDA approved the first generic version of Mylan's EpiPen, a lifesaving medication for severe allergic reactions.
February 2018
- FDA approves new treatment for multiple sclerosis: The FDA approved Ocrevus (ocrelizumab), a new treatment for relapsing forms of multiple sclerosis.
March 2018
- FDA approves first generic version of Nexium: The FDA approved the first generic version of AstraZeneca's Nexium, a medication for heartburn and acid reflux.
April 2018
- FDA approves new treatment for rare genetic disorder: The FDA approved Brineura (cerliponase alfa), a new treatment for a rare genetic disorder called CLN2 disease.
May 2018
- FDA approves new treatment for breast cancer: The FDA approved AstraZeneca's Lynparza (olaparib), a new treatment for certain types of breast cancer.
June 2018
- FDA approves new treatment for type 2 diabetes: The FDA approved Novo Nordisk's Rybelsus (semaglutide), a new treatment for type 2 diabetes.
July 2018
- FDA approves new treatment for rare blood disorder: The FDA approved Bluebird Bio's Zynteglo (betibeglogene autotemcel), a new treatment for a rare blood disorder called beta-thalassemia.
August 2018
- FDA approves new treatment for multiple myeloma: The FDA approved Bristol-Myers Squibb's Empliciti (elotuzumab), a new treatment for multiple myeloma.
September 2018
- FDA approves new treatment for rare genetic disorder: The FDA approved BioMarin's Brineura (cerliponase alfa), a new treatment for a rare genetic disorder called CLN2 disease.
October 2018
- FDA approves new treatment for depression: The FDA approved Allergan's Vybare (vilazodone), a new treatment for depression.
November 2018
- FDA approves new treatment for rare genetic disorder: The FDA approved Pfizer's Vyndaqel (tafamidis), a new treatment for a rare genetic disorder called transthyretin amyloidosis.
December 2018
- FDA approves new treatment for type 2 diabetes: The FDA approved Eli Lilly's Mounjaro (tirzepatide), a new treatment for type 2 diabetes.
These are just a few examples of the many FDA approvals and news stories from 2018.